Streamline Health Solutions Stock Piotroski F Score
STRM Stock | USD 0.36 0.03 9.09% |
Streamline | Piotroski F Score |
At this time, it appears that Streamline Health's Piotroski F Score is Poor. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Poor
Current Return On Assets | Negative | Focus |
Change in Return on Assets | Increased | Focus |
Cash Flow Return on Assets | Negative | Focus |
Current Quality of Earnings (accrual) | Improving | Focus |
Asset Turnover Growth | Increase | Focus |
Current Ratio Change | Increase | Focus |
Long Term Debt Over Assets Change | Higher Leverage | Focus |
Change In Outstending Shares | Increase | Focus |
Change in Gross Margin | No Change | Focus |
Streamline Health Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Streamline Health is to make sure Streamline is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Streamline Health's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Streamline Health's financial numbers are properly reported.
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Asset Turnover | 0.8 | 0.47 |
|
| |||||
Gross Profit Margin | 0.4 | 0.42 |
|
| |||||
Total Current Liabilities | 10 M | 19.3 M |
|
| |||||
Total Assets | 74.3 M | 70.7 M |
|
| |||||
Total Current Assets | 12.8 M | 18.4 M |
|
|
Streamline Health F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Streamline Health's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Streamline Health in a much-optimized way.
Click cells to compare fundamentals
About Streamline Health Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.Book Value Per Share |
|
Streamline Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Streamline Health from analyzing Streamline Health's financial statements. These drivers represent accounts that assess Streamline Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Streamline Health's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 25.0M | 60.9M | 58.7M | 106.5M | 95.9M | 100.7M | |
Enterprise Value | 27.2M | 61.2M | 58.9M | 109.7M | 98.7M | 103.7M |
About Streamline Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Streamline Health Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Streamline Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Streamline Health Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:Check out Streamline Health Altman Z Score, Streamline Health Correlation, Streamline Health Valuation, as well as analyze Streamline Health Alpha and Beta and Streamline Health Hype Analysis. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Streamline Stock analysis
When running Streamline Health's price analysis, check to measure Streamline Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Streamline Health is operating at the current time. Most of Streamline Health's value examination focuses on studying past and present price action to predict the probability of Streamline Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Streamline Health's price. Additionally, you may evaluate how the addition of Streamline Health to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Streamline Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (0.35) | Revenue Per Share 0.428 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.